Cargando…
Chronic AMPK activity dysregulation produces myocardial insulin resistance in the human Arg302Gln-PRKAG2 glycogen storage disease mouse model
BACKGROUND: The cardiac PRKAG2 mutation in the γ2-subunit of adenosine monophosphate activated kinase (AMPK) is characterized by excessive glycogen deposition, hypertrophy, frequent arrhythmias, and progressive conduction system disease. We investigated whether myocardial glucose uptake (MGU) was au...
Autores principales: | Thorn, Stephanie L, Gollob, Michael H, Harper, Mary-Ellen, Beanlands, Rob S, deKemp, Robert A, DaSilva, Jean N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707764/ https://www.ncbi.nlm.nih.gov/pubmed/23829931 http://dx.doi.org/10.1186/2191-219X-3-48 |
Ejemplares similares
-
Decreased renal AT(1) receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartan
por: Ismail, Basma, et al.
Publicado: (2016) -
Cardiomiopatia PRKAG2
por: Sternick, Eduardo Back
Publicado: (2022) -
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT(1) receptor expression as measured with PET imaging
por: Ismail, Basma, et al.
Publicado: (2017) -
(82)Rb PET imaging of myocardial blood flow—have we achieved the 4 “R”s to support routine use?
por: deKemp, Robert A., et al.
Publicado: (2016) -
Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease
por: Hu, Dan, et al.
Publicado: (2020)